Anocca Doses First Patients in VIDAR-1 Trial of ANOC-001 TCR-T Therapy for KRAS-Mutated Pancreatic Cancer Anocca AB, a clinical-stage biotechnology company focused on the development of advanced T-cell immunotherapies, has…
Genentech’s Tecentriq Moves Closer to Potential New Standard of Care in Early Colon Cancer Following FDA Priority Review Acceptance Genentech, a member of the Roche Group, has announced that the…
Galderma Global Survey Reveals Rising Demand for Long-Lasting, Natural-Looking Anti-Wrinkle Treatments Galderma has unveiled the results of a major international survey examining the expectations, preferences, and experiences of both patients…
GENESIS Pharma and Alnylam Expand Strategic Partnership to Bring RNAi Therapies to Nordic Markets GENESIS Pharma has announced a significant expansion of its long-standing collaboration with Alnylam Pharmaceuticals, further strengthening…
Roquette to Showcase Advanced Drug Delivery and Pharmaceutical Solutions at CPHI & PMEC China 2026 Roquette, a global leader in plant-based ingredients and pharmaceutical excipients, has announced its participation in…
Vir Biotechnology Appoints Timothy Coughlin to Board of Directors and Audit Committee Leadership Role Vir Biotechnology has announced the appointment of Timothy Coughlin to its Board of Directors, effective June…
Poxel Appoints Yves Decadt as Chief Executive Officer to Lead Next Phase of Growth and Strategic Development French biopharmaceutical company Poxel has announced the appointment of Yves Decadt as its…
KARL STORZ Receives FDA Clearance for Rubina™ Lens Exoscope, Expanding Near-Infrared Imaging Capabilities in Open Surgery KARL STORZ, a global leader in endoscopic and minimally invasive surgical technologies, has announced…
Watchmaker Genomics Unveils New Sequencing Technologies to Improve NGS Workflow Efficiency and Data Accuracy at ESHG 2026 Watchmaker Genomics, a company recognized for its high-performance next-generation sequencing (NGS) workflow solutions,…
Covalon Appoints New Board Director and Awards Deferred Share Units (DSUs) Covalon Technologies Ltd., an advanced medical technologies company listed on the TSX Venture Exchange, has announced the appointment of…
OpenEvidence and the American Academy of Ophthalmology Partner to Bridge the Gap Between Evidence and Clinical Eye Care American Academy of Ophthalmology, the world’s largest association of eye physicians and…
Element Biosciences Raises Upsized Series E to Accelerate Global Expansion Across Genomic, Multiomic, and Clinical Research Solutions Ecosystem Element Biosciences has announced an upsized Series E financing round, anchored by…